Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2026-01-08 @ 12:05 AM
Study NCT ID:
NCT04649060
Status:
TERMINATED
Last Update Posted:
2023-06-08
First Post:
2020-11-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Melflufen (Melphalan Flufenamide) in Combination With Daratumumab in Relapsed-Refractory Multiple Myeloma
Sponsor:
Oncopeptides AB
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-21
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-07
Completion Date Type:
ACTUAL
First Submit Date:
2020-11-24
First Submit QC Date:
None
Study First Post Date:
2020-12-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-02-07
Results First Submit QC Date:
None
Results First Post Date:
2023-06-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-12
Last Update Post Date:
2023-06-08
Last Update Post Date Type:
ACTUAL